Company news
ABVC BioPharma, Inc. news in 2021
ABVC BioPharma, Inc.'s news releases, calls and decks from 2021, newest first.
ABVC Biopharma Reports Third Quarter 2021 Financial and Operational Results
November 14, 2021
ABVC Biopharma Receives Additional $4,245,000 from Exercise of Warrants, Total Capital from Public Offering Increases to Approx. $11.1M
November 10, 2021
ABVC BioPharma Completes Site Selection for ABV-1505 ADHD Phase II Part 2 Clinical Study
September 12, 2021
ABVC BioPharma Announces New PCT Filings for MDD and ADHD Treatments
August 31, 2021
ABVC BioPharma Reports Second Quarter 2021 Results
August 11, 2021
ABVC BioPharma, Inc. Announces Pricing of $6.875 Million Firm Commitment Offering
August 2, 2021